Plexon Inc Celebrates 30 Years in Neuroscience Research, Record Sales and a New Website
News Jan 30, 2013
Today's celebration unleashes bold new branding, a completely redesigned website, the company's first publication grant contest, product promotions, marketing programs and extended service hours.
Decades ago, Harvey Wiggins, Plexon's president, designed the industry's first high channel count data acquisition system to more effectively facilitate the recording and analysis of brain signals. Today, Plexon proudly serves thousands of customers in nearly 40 countries. Plexon thrived in 2012 closing double digit growth that yielded record sales. To meet increasing demand, Plexon grew its employee base by nearly 30%. Its stats are especially impressive considering the disappointing ~2% growth of the U.S. economy, and the hardly better ~4% growth of the U.S. scientific research and development market.
To punctuate its strength and long-term vision, Plexon launched a bold new look and a top tier website providing exceptionally easy-to-navigate, open access to a wealth of content. Further, Plexon is offering two rare promotions for its Offline Sorter (OFS), the most trusted offline spike sorting software cited in more than 800 publications. When purchasing OFS, researchers may choose either an extra license key (a $2,000+ value), or special pricing (nearly a $1,000 value).
As part of the celebration and in partnership with the Journal of Visualized Experiments (JoVE), Plexon announces the first Publication Grant Contest -- valued at $4,200. Researchers are encouraged to submit abstracts about research performed using the OmniPlex® Neural Data Acquisition System. The winner's research will be peer-reviewed, published in video and text formats, and freely accessible at www.jove.com.
MIT researchers have developed a cryptographic system that could help neural networks identify promising drug candidates in massive pharmacological datasets, while keeping the data private. Secure computation done at such a massive scale could enable broad pooling of sensitive pharmacological data for predictive drug discovery.
The architecture of each person’s brain is unique, and differences may influence how quickly people can complete various cognitive tasks.o learn more, scientists are developing a new tool — computational models of the brain — to simulate how the structure of the brain may impact brain activity and, ultimately, human behavior.READ MORE